Topics
TWILIO INC., $68.76, is a buy. The company (Nasdaq symbol TWLO; TSINetwork Rating: Extra Risk) (www.twilio.com; Shares outstanding: 173.3 million; Market cap: $13.0 billion; No dividends paid) now plans to lay off 11% of its workforce....
Demand for Major Drilling’s specialized services, especially from senior gold producers, including Australia’s largest mining companies, is now recovering. Meanwhile, Computer Modelling is benefiting from expanding oil and gas drilling in response to higher energy prices....
The plunge for many tech/platform stocks since the start of this year has hit both high-growth stocks with strong prospects as well as others with weaker outlooks that you should remain wary of despite broker/media praise for their business models. Here’s an example of a stock to stay away from:
WAG! GROUP CO., $3.33, (Nasdaq symbol PET; TSINetwork Rating: Speculative) (www.wag.co; Shares o/s: 37.9 million; Market cap: $126.3 million; No dividend) is the developer of a mobile-first technology platform that provides on-demand and scheduled pet-care services such as dog walking, training, pet sitting, etc....
WAG! GROUP CO., $3.33, (Nasdaq symbol PET; TSINetwork Rating: Speculative) (www.wag.co; Shares o/s: 37.9 million; Market cap: $126.3 million; No dividend) is the developer of a mobile-first technology platform that provides on-demand and scheduled pet-care services such as dog walking, training, pet sitting, etc....
Canada legalized cannabis four years ago. Still, while demand has been steady, stiff competition has cut selling prices significantly. Meanwhile, advertising restrictions and plain packaging rules make it hard to build brands that win customer loyalty. Still, we think some companies have a distinct edge—including their prospects for added sales in the U.S....
WALT DISNEY CO., $98.99, is a buy. The company (New York symbol DIS; TSINetwork Rating: Above Average) (www.disney.com; Shares o/s: 1.8 billion; Market cap: $179.5 billion; No dividend) has now added Carolyn Everson, a veteran technology and media executive, most recently president of grocery delivery company Instacart, to its board of directors....
One Successful Investor way to cut IPO risk is to wait till a new issue has survived a market slump. 2019 IPO PagerDuty dropped to near $13 in March 2020 as COVID-19 took hold. But its business has continued to prosper by applying artificial intelligence (AI) to help customers shorten or avoid disruptions and to save money. We recommend this stock as a Power Buy.
PAGERDUTY INC., $22.47, is a buy. The company (New York symbol PD; TSINetwork Rating: Extra Risk) (www.pagerduty.com; Shares outstanding: 89.2 million; Market cap: $2.1 billion; No dividends paid) operates a platform that collects real-time data from software systems and devices and then notifies its IT customers of any incident that could harm their operations.
PagerDuty’s platform sits on top of a company’s technology systems, taking in data....
PAGERDUTY INC., $22.47, is a buy. The company (New York symbol PD; TSINetwork Rating: Extra Risk) (www.pagerduty.com; Shares outstanding: 89.2 million; Market cap: $2.1 billion; No dividends paid) operates a platform that collects real-time data from software systems and devices and then notifies its IT customers of any incident that could harm their operations.
PagerDuty’s platform sits on top of a company’s technology systems, taking in data....
Eli Lilly discovers, develops, manufactures, and markets human pharmaceutical products—and it now has an obesity drug with a bright future that’s being fast-tracked by the FDA.
ELI LILLY & CO., $329.29, is a buy. The company (New York symbol LLY; TSINetwork Rating: Above Average) (www.lilly.com; Shares o/s: 950.2 million; Market cap: $318.3 billion; Dividend yield: 1.2%) said that the U.S....
ELI LILLY & CO., $329.29, is a buy. The company (New York symbol LLY; TSINetwork Rating: Above Average) (www.lilly.com; Shares o/s: 950.2 million; Market cap: $318.3 billion; Dividend yield: 1.2%) said that the U.S....
MERCK & CO. INC., $93.26, is a #1 Power Buy for 2022. The drugmaker (New York symbol MRK; TSINetwork Rating: Above Average) (www.merck.com; Shares outstanding: 2.5 billion; Market cap: $239.7 billion; Dividend yield: 3.0%) has now exercised an option to jointly develop and potentially sell an mRNA-based cancer vaccine along with Moderna (symbol MRNA on Nasdaq).
The vaccine, mRNA-4157, is being tested in conjunction with Merck’s blockbuster cancer immunotherapy Keytruda, in a mid-stage trial for patients with high-risk melanoma....
The vaccine, mRNA-4157, is being tested in conjunction with Merck’s blockbuster cancer immunotherapy Keytruda, in a mid-stage trial for patients with high-risk melanoma....
We continue to see attractive investment opportunities for our subscribers in top drug stocks—and that includes AbbVie Inc. At the same time, over the years, we’ve found that spinoffs are about as close as you can get to a sure thing in investing. It’s one key reason why we think AbbVie—itself a spinoff—has further gains ahead for investors. We recommend this stock as a Power Buy.
ABBVIE INC., $143.13, is a buy. The company (New York symbol ABBV; TSINetwork Rating: Above Average) (www.abbvie.com; Shares outstanding: 1.8 billion; Market cap: $255.7 billion; Dividend yield: 3.9%) was formed on January 3, 2013, when Abbott Laboratories (symbol ABT on New York) split into two publicly traded companies.
Since its spinoff from Abbott Laboratories, AbbVie has depended heavily on its Humira drug to drive both its sales and earnings....
ABBVIE INC., $143.13, is a buy. The company (New York symbol ABBV; TSINetwork Rating: Above Average) (www.abbvie.com; Shares outstanding: 1.8 billion; Market cap: $255.7 billion; Dividend yield: 3.9%) was formed on January 3, 2013, when Abbott Laboratories (symbol ABT on New York) split into two publicly traded companies.
Since its spinoff from Abbott Laboratories, AbbVie has depended heavily on its Humira drug to drive both its sales and earnings....
INTEL CORP. $26 is a buy. The company (Nasdaq symbol INTC; Manufacturing & Industry sector; Shares o/s: 4.1 billion; Market cap: $106.6 billion; Dividend yield: 5.6%; Takeover Target Rating: Medium; www.intel.com) acquired Israel-based Mobileye, which specializes in computer systems and chips for self-driving cars, in 2017 for $15.7 billion.
Intel now plans to sell 41 million shares in Mobileye to the public for $18 to $20 each....
Intel now plans to sell 41 million shares in Mobileye to the public for $18 to $20 each....